Mutations or loss of IFN-γ pathway-related proteins on tumor cells (such as STATs, IFN-γ receptor chain JAK1 and JAK2) can cause escape from immune recognition and resistance to immune checkpoint inhibitions [68,86]. Here, IFNG is linked to neoplasm.